UK guideline for managing meningococcal disease in university settings may have relevance for other European countries
(10 April 2005: VIDYYA MEDICAL NEWS SERVICE) -- James Stuart1,3 (email@example.com)
and Anne Perrocheau2,3
1Health Protection Agency South West, Gloucester, England
3Institut de veille sanitaire, Saint-Maurice, France
2European Monitoring Group for Meningococci
Universities in the UK are increasingly aware that cases of meningococcal
disease cause great distress and disturbance on campuses. Living arrangements and student lifestyles pose particular problems in public health management: for example, many students in the UK study at universities far from their home towns, and live in one-person rooms within halls of residence that may accommodate several hundred students. Misinformation about incidents may spread quickly and panic can easily result. Students who have recently left home may feel vulnerable especially if they have not yet established good access to local primary care services.
A peak of incidence in meningococcal disease in late teenage years is well
recognized, and this peak corresponds with the age at which most students
start university and at which the prevalence of carriage is rising [2,3].
University students in the UK are at higher risk compared with non-students
of the same age group . The risk is highest among first year students
. Students starting university are likely to be exposed to a wide variety
of meningococcal strains, many of which they may not have encountered previously,
and in a setting where extensive social interaction occurs.
This publication provides advice on drawing up plans for universities and
public health services with suggested action before and after cases occur.
Preventive advice includes checking for immunisation with meningococcal
conjugate C vaccine, recommended in the UK up to the age of 25 years. The
guidelines propose that each university formulate a management protocol
for dealing with cases and outbreaks. Prompt and accurate communication
to raise awareness of symptoms in students and healthcare providers, and
to provide reassurance to students, is essential. Effective systems are
recommended for monitoring and supporting students during illness, and providing
rapid medical assistance when necessary.
Although the UK guideline for students is a practical and complete document
that addresses pathogenesis and transmission of Neisseria meningitidis
and control strategies to limit mortality and morbidity of the disease among
universities students in UK, this guideline has much less relevance in European
countries such as France, because students tend to continue to live in the
family home during their university education, or to share apartments with
a handful of other students, and they tend to socialise in smaller groups.
Therefore this group is not considered as a high risk group for meningococcal
disease. In France, the rate of meningococcal disease in teenagers (15-19
years old) is higher than in older age groups  and is associated with
social behaviour rather than any particular living conditions.
Although the pathogenicity of N. meningitidis is universal, large
differences in incidence rates are observed in Europe, both between neighbouring
countries and within the same country. This reflects differences in the
epidemiology of the circulating clones, environmental factors such as living
conditions, and perhaps also some genetic factors and the national control
strategy policies. Vaccination programmes are the primary prevention tool
for meningococcal disease, but rapid identification and medical care seeking
to limit fatality and sequelae and to prevent secondary cases are very important,
and countries that have already produced recommendations addressing these
issues should share these with countries that do not have the benefit of
expertise or capacity to establish national guidelines. Comparisons of guidelines,
and of the impact of those guidelines, are crucial to better control the
disease at national and European level .
Health Protection Agency and Public Health Medicine Environmental Group
et al. Managing meningococcal disease (septicaemia or meningitis) in
higher education institutions. London: Universities UK; December 2004.
Jones DM, Mallard R. Age incidence of meningococcal disease in England
and Wales, 1984-1991. J Infect 1993; 27:83-88.
Ramsay M, Kaczmarski EB, Rush M, Mallard R, Farrington P, White J. Changing
patterns of case ascertainment and trends in meningococcal disease in England
and Wales. Commun Dis Rep Rev 1997; 7(4):R49-R54.
Neal KR, Nguyen-Van-Tam J, Monk P, O'Brien SJ, Stuart J, Ramsay M. Invasive
meningococcal disease among university undergraduates: association with
universities providing relatively large amounts of catered hall accommodation.
Epidemiol Infect 1999; 122:351-357.
Health Protection Agency Communicable Disease Surveillance Centre, London,
United Kingdom: unpublished data.
Perrocheau A., Levy-Bruhl D. Les infections invasives à méningocoques
en France en 2003. Bulletin Epidémiologique Hebdomadaire 2004
(46): 217-20. (http://www.invs.sante.fr/beh/2004/46/beh_46_2004.pdf)
Purcell B, Samuelsson S, Hahne SJ, Ehrhard I, Heuberger S, Camaroni I,
et al. Effectiveness of antibiotics in preventing meningococcal disease
after a case: systematic review. BMJ 2004; 328(7452):1339.
Return to Vidyya Medical News Service for 10 April 2005